Consequently, GSK3β inhibitors in the mPFC cause reduced prepulse inhibition [58], which reflects a dysfunction in sensorimotor gating—a feature reported in patients with psychiatric disorders such as bipolar disorder and schizophrenia [211]. Here, GSK3B is linked to schizophrenia.